Suppr超能文献

免疫和病毒学发现一例治疗后控制异常的患者:病例报告。

Immunological and virological findings in a patient with exceptional post-treatment control: a case report.

机构信息

Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain.

Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain.

出版信息

Lancet HIV. 2023 Jan;10(1):e42-e51. doi: 10.1016/S2352-3018(22)00302-2. Epub 2022 Oct 27.

Abstract

BACKGROUND

Although antiretroviral therapy (ART) is effective in suppressing viral replication, HIV-1 persists in reservoirs and rebounds after ART has been stopped. However, a very few people (eg, elite and post-treatment controllers) are able to maintain viral loads below detection limits without ART, constituting a realistic model for long-term HIV remission. Here, we describe the HIV control mechanisms of an individual who showed exceptional post-treatment control for longer than 15 years.

METHODS

We report the case of a Hispanic woman aged 59 years with sexually acquired acute HIV infection, who was included in an immune-mediated primary HIV infection trial involving a short course of ciclosporine A, interleukin-2, granulocyte macrophage colony-stimulating factor, and pegylated interferon alfa, followed by analytical treatment interruption. We did the following viral assays: total and integrated HIV-1 DNA in CD4 T cells and rectal tissue, quantitative viral outgrowth assay, HIV-1 infectivity in peripheral blood mononuclear cells and CD4 T-cell cultures and viral inhibitory activity by natural killer (NK) and CD8 T cells. NK and T-cell phenotypes were determined by flow cytometry. HLA, killer cell immunoglobulin-like receptors, Δ32CCR5, and NKG2C alleles were genotyped.

FINDINGS

After ART and immunomodulatory treatment, the person maintained undetectable plasma viral load for 15 years. HIV-1 subtype was CFR_02AG, CCR5-tropic. We found progressive reductions in viral reservoir during the 15-year treatment interruption: total HIV DNA (from 4573·50 copies per 10 CD4 T cells to 95·33 copies per 10 CD4 T cells) and integrated DNA (from 85·37 copies per 10 CD4 T cells to 5·25 copies per 10 CD4 T cells). Viral inhibition assays showed strong inhibition of in vitro HIV replication in co-cultures of CD4 T cells with autologous NK or CD8 T cells at 1:2 ratio (75% and 62%, respectively). Co-cultures with NK and CD8 T cells resulted in 93% inhibition. We detected higher-than-reference levels of both NKG2C-memory-like NK cells (46·2%) and NKG2C γδ T cells (64·9%) associated with HIV-1 control.

INTERPRETATION

We described long-term remission in a woman aged 59 years who was treated during primary HIV infection and has maintained undetectable viral load for 15 years without ART. Replication-competent HIV-1 was isolated. NKG2C-memory-like NK cells and γδ T cells were associated with the control viral replication. Strategies promoting these cells could bring about long-term HIV remission.

FUNDING

Fondo Europeo para el Desarrollo Regional (FEDER), SPANISH AIDS Research Network (RIS), Fondo de Investigación Sanitaria (FIS), HIVACAT, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CERCA Programme/Generalitat de Catalunya, la Caixa Foundation, and Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC).

TRANSLATION

For the Spanish translation of the abstract see Supplementary Materials section.

摘要

背景

尽管抗逆转录病毒疗法(ART)可有效抑制病毒复制,但 HIV-1 仍存在于储库中,并在停止 ART 后反弹。然而,极少数人(例如精英和治疗后控制者)能够在没有 ART 的情况下将病毒载量维持在检测限以下,这构成了长期 HIV 缓解的现实模型。在这里,我们描述了一名个体的 HIV 控制机制,该个体在超过 15 年的时间内表现出异常的治疗后控制。

方法

我们报告了一名 59 岁西班牙裔女性的病例,她患有性传播的急性 HIV 感染,她参与了一项免疫介导的原发性 HIV 感染试验,包括短期环孢素 A、白细胞介素-2、粒细胞巨噬细胞集落刺激因子和聚乙二醇化干扰素 alfa 治疗,随后进行了分析性治疗中断。我们进行了以下病毒检测:CD4 T 细胞和直肠组织中的总和整合 HIV-1 DNA、定量病毒外生测定、外周血单核细胞和 CD4 T 细胞培养物中的 HIV-1 感染性以及自然杀伤(NK)和 CD8 T 细胞的病毒抑制活性。通过流式细胞术确定 NK 和 T 细胞表型。鉴定了 HLA、杀伤细胞免疫球蛋白样受体、Δ32CCR5 和 NKG2C 等位基因。

结果

在 ART 和免疫调节治疗后,该人在 15 年内保持了无法检测到的血浆病毒载量。HIV-1 亚型为 CFR_02AG,CCR5 嗜性。我们发现,在 15 年的治疗中断期间,病毒库逐渐减少:总 HIV DNA(从每 10 CD4 T 细胞 4573.50 个拷贝减少到每 10 CD4 T 细胞 95.33 个拷贝)和整合 DNA(从每 10 CD4 T 细胞 85.37 个拷贝减少到每 10 CD4 T 细胞 5.25 个拷贝)。体外 HIV 复制抑制试验显示,在 CD4 T 细胞与自体 NK 或 CD8 T 细胞的共培养物中,HIV 复制分别得到 75%和 62%的强烈抑制。与 NK 和 CD8 T 细胞的共培养导致 93%的抑制。我们检测到与 HIV-1 控制相关的 NKG2C 记忆样 NK 细胞(46.2%)和 NKG2C γδ T 细胞(64.9%)的水平高于参考值。

解释

我们描述了一名 59 岁女性的长期缓解情况,该女性在原发性 HIV 感染期间接受了治疗,并在 15 年内未接受 ART 治疗而保持了无法检测到的病毒载量。分离出了具有复制能力的 HIV-1。NKG2C 记忆样 NK 细胞和 γδ T 细胞与控制病毒复制有关。促进这些细胞的策略可能会带来长期的 HIV 缓解。

资金

欧洲区域发展基金(FEDER)、西班牙艾滋病研究网络(RIS)、西班牙卫生研究基金(FIS)、HIVACAT、巴塞罗那艾滋病研究所(IDIBAPS)、CERC 计划/加泰罗尼亚政府、La Caixa 基金会和传染病研究生物医学网络(CIBERINFEC)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验